Melioidosis Research Center, KhonKaen University, KhonKaen, Thailand.
PLoS One. 2010 Feb 12;5(2):e9196. doi: 10.1371/journal.pone.0009196.
Burkholderia pseudomallei, a gram-negative bacterium that causes melioidosis, was reported to produce biofilm. As the disease causes high relapse rate when compared to other bacterial infections, it therefore might be due to the reactivation of the biofilm forming bacteria which also provided resistance to antimicrobial agents. However, the mechanism on how biofilm can provide tolerance to antimicrobials is still unclear.
METHODOLOGY/PRINCIPAL FINDINGS: The change in resistance of B. pseudomallei to doxycycline, ceftazidime, imipenem, and trimethoprim/sulfamethoxazole during biofilm formation were measured as minimum biofilm elimination concentration (MBEC) in 50 soil and clinical isolates and also in capsule, flagellin, LPS and biofilm mutants. Almost all planktonic isolates were susceptible to all agents studied. In contrast, when they were grown in the condition that induced biofilm formation, they were markedly resistant to all antimicrobial agents even though the amount of biofilm production was not the same. The capsule and O-side chains of LPS mutants had no effect on biofilm formation whereas the flagellin-defective mutant markedly reduced in biofilm production. No alteration of LPS profiles was observed when susceptible form was changed to resistance. The higher amount of N-acyl homoserine lactones (AHLs) was detected in the high biofilm-producing isolates. Interestingly, the biofilm mutant which produced a very low amount of biofilm and was sensitive to antimicrobial agents significantly resisted those agents when grown in biofilm inducing condition.
CONCLUSIONS/SIGNIFICANCE: The possible drug resistance mechanism of biofilm mutants and other isolates is not by having biofilm but rather from some factors that up-regulated when biofilm formation genes were stimulated. The understanding of genes related to this situation may lead us to prevent B. pseudomallei biofilms leading to the relapse of melioidosis.
伯氏考克斯体是一种革兰氏阴性细菌,可导致类鼻疽病。据报道,该细菌会产生生物膜。由于与其他细菌感染相比,该病的复发率较高,因此可能是由于生物膜形成细菌的复活所致,而这些细菌也对抗生素产生了耐药性。然而,生物膜如何提供对抗生素的耐受性的机制尚不清楚。
方法/主要发现:通过测定 50 株土壤和临床分离株以及荚膜、鞭毛、脂多糖和生物膜突变株中最小生物膜消除浓度(MBEC),测量了伯氏考克斯体形成生物膜过程中对抗生素多西环素、头孢他啶、亚胺培南和甲氧苄啶/磺胺甲恶唑的耐药性变化。几乎所有浮游分离株对所有研究药物均敏感。相比之下,当它们在诱导生物膜形成的条件下生长时,它们对所有抗菌药物均表现出明显的耐药性,尽管生物膜的产生量并不相同。荚膜和脂多糖 O-侧链突变体对生物膜形成没有影响,而鞭毛缺陷突变体的生物膜产生量明显减少。当从敏感表型转变为耐药表型时,未观察到脂多糖图谱的改变。在高生物膜产生分离株中检测到更高量的 N-酰基高丝氨酸内酯(AHLs)。有趣的是,当在生物膜诱导条件下生长时,产生非常少量生物膜且对抗生素敏感的生物膜突变体显著抵抗这些药物。
结论/意义:生物膜突变体和其他分离株的可能耐药机制不是通过形成生物膜,而是由于生物膜形成基因受到刺激时上调的某些因素。对与这种情况相关的基因的了解可能使我们能够防止伯氏考克斯体生物膜导致类鼻疽病的复发。